Clinical Trials in Oxford, UK | Priya Life Science

Clinical Trials in Oxford

Every industry-sponsored study on the ClinicalTrials.gov registry that lists a UK site and is open, about to open, active-but-closed, or enrolling by invitation. This deliberately excludes academic and other non-industry sponsors — the full UK registry across all sponsors is far larger. UK studies may also be registered separately on ISRCTN.

Status

Study

Lead sponsor

Phase

Enrol

UK sites

Start

Active, closed

Study of TSR-042, an Anti-programmed Cell Death-1 Receptor (PD-1) Monoclonal Antibody, in Participants With Advanced Solid Tumors

NCT02715284Neoplasms

Tesaro, Inc.

Phase 1

729

Newcastle upon Tyne, Aberdeen, London, Manchester, Oxford, Sutton

2016-03-07

Active, closed

A Study of Apalutamide (JNJ-56021927, ARN-509) Plus Androgen Deprivation Therapy (ADT) Versus ADT in Participants With mHSPC

NCT02489318Prostate Cancer

Aragon Pharmaceuticals, Inc.

Phase 3

1,052

Carlisle, Dundee, Glasgow, London, Newcastle upon Tyne, Oxford, Plymouth, Scunthorpe

2015-11-27

Active, closed

An Efficacy and Safety Study of JNJ-56021927 (Apalutamide) in High-risk Prostate Cancer Subjects Receiving Primary Radiation Therapy: ATLAS

NCT02531516Prostatic Neoplasms

Aragon Pharmaceuticals, Inc.

Phase 3

1,503

Aberdeen, Birmingham, Bristol, Derby, Glasgow, Oxford, Plymouth, Preston

2015-11-19

Active, closed

On-X Aortic Prosthetic Heart Valve Low Dose Warfarin Post Approval Clinical Registry Study

NCT02677974Thrombotic and Bleeding Events

On-X Life Technologies, Inc.

Observational

510

Blackpool, Hull, London, Oxford, Southampton

2015-11-10

Active, closed

Phase 1-2 Study of ASTX660 in Subjects With Advanced Solid Tumors and Lymphomas

NCT02503423Solid Tumors, Lymphoma

Taiho Oncology, Inc.

Phase 1/2

253

Leicester, Southampton, Oxford, Sutton, Birmingham, Glasgow, London, Manchester

2015-07-14

Active, closed

An Open-label, Phase 2 Study of ACP-196 (Acalabrutinib) in Subjects With Mantle Cell Lymphoma

NCT02213926Mantle Cell Lymphoma (MCL)

Acerta Pharma BV

Phase 2

124

Cardiff, Leeds, Leicester, Nottingham, Oxford, Plymouth, Southampton

2015-03-02

By invitation

Registry of Patients With Hypophosphatasia

NCT02306720Hypophosphatasia (HPP)

Alexion Pharmaceuticals, Inc.

Observational

1,571

Bristol, London, Leicester, Stanmore, Oxford, Sheffield, Newcastle upon Tyne, Birmingham

2015-01-20

Active, closed

Ascending Doses of Ceralasertib in Combination With Chemotherapy and/or Novel Anti Cancer Agents

NCT02264678Adv Solid Malig - H&N SCC, ATM Pro / Def NSCLC, Gastric, Breast and Ovarian Cancer

AstraZeneca

Phase 1

358

Bristol, Cambridge, Coventry, London, Manchester, Oxford, Sutton, Withington

2014-10-31

Active, closed

An Open-label, Phase 2 Study of ACP-196 in Subjects With Waldenström Macroglobulinemia

NCT02180724Waldenström Macroglobulinemia (WM)

Acerta Pharma BV

Phase 2

107

Bournemouth, Leeds, Leicester, London, Oxford, Plymouth, Southampton

2014-09-11

Recruiting

Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry

NCT02071134Parkinson's Disease

Boston Scientific Corporation

Observational

1,500

Bristol, Glasgow, Liverpool, London, Newcastle, Oxford

2014-03-04

Active, closed

ACP-196 (Acalabrutinib), a Novel Bruton Tyrosine Kinase (BTK) Inhibitor, for Treatment of Chronic Lymphocytic Leukemia, Richter's Syndrome or Prolymphocytic Leukemia

NCT02029443Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Richter's Syndrome, Prolymphocytic Leukemia

Acerta Pharma BV

Phase 1/2

306

Leeds, London, Oxford

2014-01-30

Active, closed

Continuum Ceramic on Ceramic Bearing Post Market Clinical Follow-Up Study

NCT03343171Osteoarthritis, Avascular Necrosis, Inflammatory Arthritis, Post-traumatic Arthritis

Zimmer Biomet

Observational

203

Glasgow, Oxford, Southampton

2010-09-15

Active, closed

Phase I Comparative Bioavailability Study

NCT00777582Solid Tumors

AstraZeneca

Phase 1

197

Edinburgh, London, Manchester, Newcastle upon Tyne, Northwood, Oxford, Sutton

2008-10-27

Cite this view

Priya Life Science (2026). Clinical trial register: industry-sponsored studies with a UK investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 20 September 2026. https://priyalifescience.com/clinical-trials-uk/city/oxford

Query this register directly

GET /api/trials?country=uk&status=recruiting&format=json Try it now →